Maeda, Yoshiko http://orcid.org/0009-0006-6115-2755
Abe, Akihito http://orcid.org/0009-0005-8799-5438
Seki, Seigo http://orcid.org/0009-0001-1501-9981
Narii, Nobuhiro http://orcid.org/0000-0002-0826-1358
Katsura, Yasuhiro http://orcid.org/0009-0000-7738-1970
Muramatsu, Yukiko http://orcid.org/0009-0006-2394-3556
Sakaguchi, Motonobu http://orcid.org/0000-0003-2310-6812
Funding for this research was provided by:
Takeda Pharmaceutical Company
Article History
Accepted: 5 August 2024
First Online: 21 August 2024
Declarations
:
: Funding of this survey was provided by Takeda Pharmaceutical Company Limited. The open access fee was provided by Takeda Pharmaceutical Company Limited.
: All authors are full-time employees of Takeda Pharmaceutical Company Limited.
: The data that supports the findings of this study are available from the corresponding author upon reasonable request.
: All procedures in this survey complied with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The survey was reviewed and approved by the Ethics Committee of Kitamachi Clinic (May 17, 2023, TKD09522).
: Persons participating in the study were informed of the targets of the investigation, the intended use of data, and recipients of these data.
: Not applicable.
: Not applicable.
: All authors contributed, critically reviewed drafts of the manuscript and approved the final version.